A Prospective Observational Study to Identify the Role of Magnesium as a Prognostic Indicator in Critically Ill Patients Admitted in the ICU of a Tertiary Care Centre in South India
KK Shameel, Ashwathi Gangadharan, AV Gayathri
Keywords :
Critical care, Hypomagnesaemia, Magnesium, Mortality, Ventilatory support
Citation Information :
Shameel K, Gangadharan A, Gayathri A. A Prospective Observational Study to Identify the Role of Magnesium as a Prognostic Indicator in Critically Ill Patients Admitted in the ICU of a Tertiary Care Centre in South India. 2023; 1 (2):39-43.
Introduction: Magnesium is the fourth most common cation seen in the body. The majority of the magnesium loads are concentrated in bones, soft tissues, and muscle, while only 2% is available extracellular. Magnesium plays a crucial role in regulating enzymatic activity. Serum magnesium levels are found to have a vital role in determining the clinical outcomes of critically ill patients.
Aim: To estimate the proportion of critically ill patients with hypomagnesaemia and the predictive capacity of magnesium in assessing the outcome of the patient.
Objectives: To estimate the proportion of critically ill patients with hypomagnesaemia and the predictive capacity of magnesium in assessing the outcome of the patient. We also tried to find the correlation between serum magnesium level and APACHE-IV score, serum potassium, need for ventilatory support and duration of ICU stay.
Materials and methods: We did a prospective observational study among all critically ill patients admitted to the hospital during the study period. Serum magnesium levels were noted at the baseline, and all patients were chosen based on specific inclusion and exclusion criteria and after obtaining informed consent. The information on sociodemographic characteristics and comorbidity profiles was collected using a semi-structured questionnaire. Blood was taken to estimate serum magnesium and potassium levels and other biochemical investigations. All patients were followed up during their stay in ICU, and their clinical outcomes were noted. The association between hypomagnesaemia and other independent and outcome variables was assessed using the Chi-square test. Correlation analysis was also done to find the relation between serum magnesium and APACHE-IV scores, serum potassium, need for ventilatory support and duration of ICU stay.
Results and conclusions: We recruited around 135 critically ill patients. The proportion of patients with hypomagnesaemia was found to be 58.5%. We found a statistically significant association between hypomagnesaemia and gender and potassium levels. We could not find any significant association between serum Mg levels and duration of ICU stay, need for ventilatory support and APACHE-IV score.
Our study showed that the prevalence of hypomagnesaemia among the study participants was 58.5%. This highlights the burden of hypomagnesaemia and the importance of monitoring it. We observed a statistically significant relationship between gender and serum potassium level status and distribution of magnesium levels. We did not find any statistical association between APACHE-IV score, the need for ventilatory support and duration of ICU stay with the distribution of magnesium level even though we found that the proportion of hypomagnesaemia among all the clinical outcomes was found to be more when compared with normal and hypermagnesaemia patients. Hence, the importance of serum magnesium levels in critically ill patients cannot be underestimated.
Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia: Requested vs routine. JAMA 1990;263(22):3063–3064. PMID: 2342219.
Martin KJ, González EA, Slatopolsky E. Clinical consequences and management of hypomagnesemia. J Am Soc Nephrol 2009;20(11):2291–2295. DOI: 10.1681/ASN.2007111194.
Perazella MA. Proton pump inhibitors and hypomagnesemia: A rare but serious complication. Kidney Int 2013;83(4):553–556. DOI: 10.1038/ki.2012.462.
Geary DF, Schaefer F. Comprehensive Pediatric Nephrology E-Book: Text with CD-ROM. Elsevier Health Sciences; 2008.
Drueke T, Lacour B. Magnesium homeostasis and disorders of magnesium metabolism. Comprehensive Clin Nephrol 2007;3: 136–138.
Guerrera MP, Volpe SL, Mao JJ. Therapeutic uses of magnesium. Am Fam Physician 2009;80(2):157–162. PMID: 19621856.
Altura BM, Altura BT. Role of magnesium in patho-physiological processes and the clinical utility of magnesium ion selective electrodes. Scand J Clin Lab Invest Suppl 1996;56(224):211–234. DOI: 10.3109/00365519609088642.
Velissaris D, Karamouzos V, Pierrakos C, et al. Hypomagnesemia in critically ill sepsis patients. J Clin Med Res 2015;7(12):911–918. DOI: 10.14740/jocmr2351w.
Pham P-CT, Pham P-AT, Pham SV, et al. Hypomagnesemia: A clinical perspective. Int J Nephrol Renovasc Dis 2014:219–230. DOI: 10.2147/IJNRD.S42054.
Rubeiz GJ, Thill-Baharozian M, Hardie D, et al. Association of hypomagnesemia and mortality in acutely ill medical patients. Crit Care Med 1993;21(2):203–209. DOI: 10.1097/00003246-199302000-00010.
Koch SM, Warters RD, Mehlhorn U. The simultaneous measurement of ionized and total calcium and ionized and total magnesium in intensive care unit patients. J Crit Care 2002;17(3):203–205. DOI: 10.1053/jcrc.2002.35813.
Safavi M, Honarmand A. Admission hypomagnesemia – impact on mortality or morbidity in critically ill patients. Middle East J Anaesthesiol 2007;19(3):645–660. PMID: 18044292.
Soliman HM, Mercan D, Lobo SS, et al. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med 2003;31(4):1082–1087. DOI: 10.1097/01.CCM.0000060867.17556.A0.
Wagner CA. Disorders of renal magnesium handling explain renal magnesium transport. J Nephrol 2007;20(5):507–510. PMID: 17918133.
Pannem RB, Munamala CSR. An observational study on effects of hypomagnesemia among critically ill patients at a tertiary care hospital. Int J Adv Med 2018;5(6). DOI: 10.18203/2349-3933.ijam20184254.
Reinhart RA, Desbiens NA. Hypomagnesemia in patients entering the ICU. Crit Care Med 1985;13(6):506–507. DOI: 10.1097/00003246-198506000-00015.
Ryzen E, Wagers PW, Singer FR, et al. Magnesium deficiency in a medical ICU population. Crit Care Med 1985;13(1):19–21. DOI: 10.1097/00003246-198501000-00006.
Deheinzelin D, Negri E, Tucci M, et al. Hypomagnesemia in critically ill cancer patients: A prospective study of predictive factors. Braz J Med Biol Res 2000;33:1443–1448. DOI: 10.1590/s0100-879x2000001200007.
Guerin C, Cousin C, Mignot F, et al. Serum and erythrocyte magnesium in critically ill patients. Intensive Care Med 1996;22(8):724–727. DOI: 10.1007/BF01709512.
Lee JW. Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press 2010;8(2):72–81. DOI: 10.5049/EBP.2010.8.2.72.
Buckley MS, LeBlanc JM, Cawley MJ. Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit. Crit Care Med 2010;38(6 Suppl):S253–S264. DOI: 10.1097/CCM.0b013e3181dda0be.
Marino P. Fluid and electrolyte disorders – Magnesium. The ICU Book. Philadelphia: Lippincott, Williams and Wilkins; 2004.
Limaye C, Londhey V, Nadkart M, et al. Hypomagnesemia in critically ill medical patients. J Assoc Physicians India 2011;59:19–22. PMID: 21751660.